Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Read Article
News
2024
2023
Archive
Search news articles
September 6, 2023
Cidara Therapeutics Announces Janssen’s Election to Proceed Under its License Agreement Relating to Novel Drug-Fc Conjugates Targeting Influenza
September 5, 2023
Rallybio Presents Phase 1 Single Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5
August 18, 2023
Artiva Biotherapeutics Announces FDA Clearance of IND for AlloNK® Cell Therapy Candidate in Combination with Rituximab in Lupus Nephritis
August 10, 2023
Entrada Therapeutics Appoints Gina Chapman to its Board of Directors
August 2, 2023
IDEAYA and Amgen Achieve First-Patient-In for Clinical Evaluation of IDE397 (MAT2A) and AMG 193 (PRMT5(MTA)) Combination in MTAP(-/-) Tumors
August 1, 2023
scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion
August 1, 2023
Cidara Therapeutics Provides Update on REZZAYO™ (rezafungin for injection)
August 1, 2023
Entrada Therapeutics Receives Authorization in the United Kingdom to Initiate Phase 1 Clinical Trial of ENTR-601-44 for the Potential Treatment of Duchenne Muscular Dystrophy
July 31, 2023
Ivy Fertility Network Expands Partnership With TMRW Life Sciences As Demand Grows for Fertility Clinic Lab Automation
July 20, 2023
Cleave Therapeutics Announces Acquisition of Clinical and Preclinical Assets
« Previous Page
1
…
6
7
8
9
10
…
119
Next Page »